Close Menu

NEW YORK – The US Food and Drug Administration announced Sunday it has granted Emergency Use Authorization to Abbott Laboratories' SARS-CoV-2 IgG antibody test.

The qualitative test detects IgG antibodies in human serum, including and plasma. It uses the SARS-CoV-2 IgG Reagent kit with the SARS-CoV-2 IgG Calibrator kit on Abbott's Architect i1000SR and i2000SR systems. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.